estrogen receptor positive breast cancer
Showing 1 - 16 of 16
Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 1, 2023
Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma Trial in Canada,
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- +7 more
- Exemestane
- +6 more
-
Birmingham, Alabama
- +499 more
Nov 15, 2022
FDG PET/CT in Breast Cancer Bone Mets
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- Bone Metastases
- FDG PET/CT scan
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Oct 13, 2022
Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- AZD5363
- +2 more
-
Manchester, Greater Manchester, United Kingdom
- +20 more
Aug 5, 2022
Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)
Active, not recruiting
- Estrogen Receptor Positive Breast Cancer
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Jul 5, 2022
Estrogen Receptor Positive Breast Cancer Trial in Salt Lake City ([18F]Fluoroestradiol (FES) PET/CT)
Recruiting
- Estrogen Receptor Positive Breast Cancer
- [18F]Fluoroestradiol (FES) PET/CT
-
Salt Lake City, UtahHuntsman Cancer Institute at University of Utah
Apr 21, 2022
Breast Cancer, Estrogen Receptor Positive Breast Cancer, Node-negative Breast Cancer Trial in Boston (Breast Cancer Treatment
Completed
- Breast Cancer
- +3 more
- Breast Cancer Treatment Decision Aid for women 70+
- Usual Care
-
Boston, Massachusetts
- +1 more
Mar 10, 2022
HER-2 Positive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Worldwide (palbociclib, trastuzumab, pertuzumab)
Active, not recruiting
- HER-2 Positive Breast Cancer
- Estrogen Receptor Positive Breast Cancer
- palbociclib
- +6 more
-
San Francisco, California
- +106 more
Mar 16, 2022
Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Denver, Sarasota, Nashville (entinostat, exemestane)
Completed
- Breast Cancer
- Estrogen Receptor Positive Breast Cancer
-
Denver, Colorado
- +2 more
Dec 14, 2021
Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)
Completed
- Estrogen Receptor Positive Breast Cancer
-
Houston, Texas
- +2 more
Aug 27, 2021
Advanced Solid Tumors With an Alteration of the PIK3CA Gene, Estrogen Receptor Positive Breast Cancer Trial in Worldwide
Completed
- Advanced Solid Tumors With an Alteration of the PIK3CA Gene
- Estrogen Receptor Positive Breast Cancer
-
San Francisco, California
- +10 more
Sep 21, 2020
Estrogen Receptor Positive Breast Cancer Trial in Worldwide (AZD2014, Everolimus, Fulvestrant)
Unknown status
- Estrogen Receptor Positive Breast Cancer
- AZD2014
- +2 more
-
Angers, France
- +78 more
Feb 24, 2020
Invasive Breast Cancer, Estrogen Receptor Positive Breast Cancer Trial in Seoul
Unknown status
- Invasive Breast Cancer
- Estrogen Receptor Positive Breast Cancer
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 17, 2018
Estrogen Receptor Positive Breast Cancer Trial in Goodyear (hydroxychloroquine)
Terminated
- Estrogen Receptor Positive Breast Cancer
-
Goodyear, ArizonaWestern Regional Medical Center, Inc.
Sep 25, 2017